Overview
Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive
Status:
Completed
Completed
Trial end date:
2006-03-01
2006-03-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The purpose of this study is to confirm the safety of SH T00658ID with regard to plasma lipids, hemostatic variables, and carbohydrate metabolism. In addition, the pharmacokinetic parameter following the long term administration of SH T00658ID will be assessed.Phase:
Phase 2Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
BayerTreatments:
Contraceptive Agents
Contraceptives, Oral
Contraceptives, Oral, Sequential
Ethinyl Estradiol-Norgestrel Combination
Criteria
Inclusion Criteria:- Healthy female volunteers between 18 and 50 years requiring contraception
Exclusion Criteria:
- Pregnancy or lactation
- Any conditions that might interfere with the outcome as well as all contraindications
for OC use